Neuroblastoma is a heterogeneous disease which displays common genomic aberrations, such as deletion of parts of chromosome arms 1p and 11q, gain of 17q (14, 15), and amplification of the MYCN oncogene (16, 17). Here, MYCN is linked to neuroblastoma.